SCYNEXIS (SCYX)
(Delayed Data from NSDQ)
$1.57 USD
-0.02 (-1.26%)
Updated Sep 18, 2024 03:59 PM ET
After-Market: $1.57 0.00 (0.00%) 7:38 PM ET
4-Sell of 5 4
D Value B Growth F Momentum C VGM
Scynexis (SCYX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.00 | $8.00 | $6.00 | 340.25% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Scynexis comes to $7.00. The forecasts range from a low of $6.00 to a high of $8.00. The average price target represents an increase of 340.25% from the last closing price of $1.59.
Analyst Price Targets (3 )
Broker Rating
Scynexis currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/13/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Strong Buy |
8/9/2024 | Cantor Fitzgerald & Co | Louise Chen | Strong Buy | Strong Buy |
3/15/2024 | Guggenheim Securities | Vamil Divan | Strong Buy | Strong Buy |
1/4/2024 | Brookline Capital Markets | Kemp Dolliver | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 4 |
Average Target Price | $7.00 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 74 of 253 |
Current Quarter EPS Est: | -0.20 |
SCYX FAQs
SCYNEXIS, Inc. (SCYX) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for SCYNEXIS, Inc. (SCYX) is $7.00. The current on short-term price targets is based on 1 reports.
The forecasts for SCYNEXIS, Inc. (SCYX) range from a low of $6 to a high of $8. The average price target represents a increase of $340.25 from the last closing price of $1.59.
The current UPSIDE for SCYNEXIS, Inc. (SCYX) is 340.25%
Based on short-term price targets offered by three analysts, the average price target for Scynexis comes to $7.00. The forecasts range from a low of $6.00 to a high of $8.00. The average price target represents an increase of 340.25% from the last closing price of $1.59.